Journal article
Thrombolysis for Restoration of Patency to Haemodialysis Central Venous Catheters: A Systematic Review
Abstract
Urokinase, previously used to restore patency to thrombosed haemodialysis catheters, is now unavailable in North America.We performed systematic reviews of four questions related to the safety and efficacy of alternative agents for catheter thrombolysis, searching Medline and the Cochrane Controlled Clinical Trials Register.In dialysis patients, large case series have documented that urokinase is safe and effective (>70%% efficacy for catheter …
Authors
Clase CM; Crowther MA; Ingram AJ; Cina` CS
Journal
Journal of Thrombosis and Thrombolysis, Vol. 11, No. 2, pp. 127–136
Publisher
Springer Nature
Publication Date
April 2001
DOI
10.1023/a:1011272632286
ISSN
0929-5305
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Catheterization, Central VenousClinical Trials as TopicDose-Response Relationship, DrugFibrinolytic AgentsHemorrhageHumansKidney Failure, ChronicRandomized Controlled Trials as TopicRenal DialysisSafetyStreptokinaseThrombolytic TherapyThrombosisTissue Plasminogen ActivatorTreatment OutcomeUrokinase-Type Plasminogen ActivatorVascular Patency